Opioid Timeliness in the Emergency Department and Hospitalizations for Acute Sickle Cell Pain
JAMA Pediatrics · 01.11.2025 · 179 (11) · 1194
DOI: 10.1001/jamapediatrics.2025.2967 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JAMA Pediatrics, erschienen am 01.11.2025. Verfasst von Ibrahim Gwarzo und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Nemours Children's Health, Wilmington, Delaware. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Emergency Service, Hospital, Analgesics, Opioid, Hospitalization. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Importance Guidelines for the timely emergency department (ED) administration of opioids for acute sickle cell disease (SCD) pain lack clear evidence showing associations with reduced hospitalizations.
Objective
To evaluate the associations between the timely administration of multiple opioid doses during uncomplicated SCD pain episodes in children and hospitalization. Design, Setting, and Participants This multisite cross-sectional study used data from the Pediatric Emergency Care Applied Research Network Registry. Included were 12 pediatric EDs from children’s hospitals with comprehensive SCD centers across the US. ED visits by children younger than 19 years with uncomplicated SCD pain at any of the 12 sites between January 1, 2019, and December 31, 2021, were included. Primary diagnosis codes were used to identify visits for SCD pain; visits with any other SCD complication were excluded. Initial data analysis was conducted from April 2024 to April 2025, including revisions. After-revision analyses were done between May and June of 2025. Exposures The 2 exposures of interest were as follows: (1) time from ED arrival to first opioid administration (dichotomized as ≤60 minutes of arrival vs >60 minutes from arrival) and (2) time interval between the first and the second opioid administration (dichotomized in separate analyses as ≤30 minutes vs >30 minutes, ≤45 minutes vs >45 minutes, and ≤60 minutes vs >60 minutes). Main Outcomes and Measures The primary outcome was hospitalization at the end of an ED visit.
Results
A total of 2538 patients (mean [SD] age, 12.0 [5.0] years; 1293 male [50.9%]) were included in this study. Of 9233 ED visits, 5023 (54.4%) resulted in hospitalization. First-dose timeliness of opioid administration evaluated alone was associated with decreased hospitalizations (odds ratio [OR], 0.84; 95% CI, 0.75-0.95). Evaluating combined first- and second-dose timeliness of opioid administration for the 7853 visits (85.1%) with 2 or more opioid doses, first-opioid timeliness was associated with reduced odds of hospitalization, even when the second dose was outside 30 minutes (OR, 0.85; 95% CI, 0.74-0.98) or 45 minutes (OR, 0.84; 95% CI, 0.72-0.97). First-dose timeliness combined with a second dose within 30-minute (OR, 0.62; 95% CI, 0.52-0.75), 45-minute (OR, 0.70; 95% CI, 0.59-0.83), and 60-minute (OR, 0.78; 95% CI, 0.67-0.92) intervals achieved the lowest odds of hospitalization. Conclusions and Relevance This cross-sectional study found that timely receipt of opioids was associated with a reduction in hospitalizations for SCD pain. The largest decrease in hospitalization was achieved with the first dose within 60 minutes and the second dose within 30 minutes; however, longer second-dose durations were associated with reduced hospitalizations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Nemours Children's Health, Wilmington, Delaware.
- Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania.
- Department of Pediatrics, Section of Emergency Medicine, Medical College of Wisconsin and the Children's Research Institute of Children's Wisconsin, Milwaukee.
- Children's National Medical Center, Washington, DC.
- Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
- Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Förderung
- NHLBI NIH HHS
Zitieren
APA
Gwarzo, I., Coleman, K. D., McKinley, K., Ellison, A. M., Alpern, E. R., Corboy, J., Hariharan, S., Topoz, I., Wurtz, M., Nielsen, B., Cook, L. J., Morris, C. R., Brandow, A. M., Campbell, A. D., Liem, R. I., Nuss, R., Quinn, C. T., Thompson, A. A., Villella, A., …, & Brousseau, D. C. (2025). Opioid Timeliness in the Emergency Department and Hospitalizations for Acute Sickle Cell Pain. JAMA Pediatrics, 179(11), 1194. https://doi.org/10.1001/jamapediatrics.2025.2967
Vancouver
Gwarzo I, Coleman KD, McKinley K, Ellison AM, Alpern ER, Corboy J, et al. Opioid Timeliness in the Emergency Department and Hospitalizations for Acute Sickle Cell Pain. JAMA Pediatrics. 2025;179(11):1194. doi:10.1001/jamapediatrics.2025.2967
BibTeX
@article{Gwarzo2025,
author = {Gwarzo, Ibrahim and Coleman, Keli D and McKinley, Kenneth and Ellison, Angela M and Alpern, Elizabeth R and Corboy, Jacqueline and Hariharan, Selena and Topoz, Irina and Wurtz, Morgan and Nielsen, Blake and Cook, Lawrence J and Morris, Claudia R and Brandow, Amanda M and Campbell, Andrew D and Liem, Robert I and Nuss, Rachelle and Quinn, Charles T and Thompson, Alexis A and Villella, Anthony and King, Allison A and Baumann, Ana and Frankenberger, Warren and Brousseau, David C},
title = {Opioid Timeliness in the Emergency Department and Hospitalizations for Acute Sickle Cell Pain},
journal = {JAMA Pediatrics},
year = {2025},
volume = {179},
number = {11},
pages = {1194},
doi = {10.1001/jamapediatrics.2025.2967}
}
EUVIMED